/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the virtual meeting H.C. Wainwright BioConnect Virtual.
/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) today announced that the first patient with hepatocellular carcinoma (HCC) has been dosed with MIV-818 in a.
/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) today announced that the first patient with hepatocellular carcinoma (HCC) has been dosed with MIV-818 in a.
/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the Erik Penser Bank Life Science Day, Thursday December.
/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) today announced that IGM Biosciences, Inc. has initiated its clinical study in solid cancers with birinapant.